Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Interactions Between PD-1 and PD-L1 and PD-L2 Promote Malignant B-Cell Growth in Waldenstrom Macroglobulinemia

Deanna M. Grote, Steven C. Ziesmer, Lucy S. Hodge, PharmD, Ph.D., Tammy L. Price-Troska, Anne J. Novak, Ph.D., Zhi-Zhang Yang, MD, Stephen M Ansell, M.D.Ph.D.

Blood (2013) 122 (21): 4334.

https://doi.org/10.1182/blood.V122.21.4334.4334

Published: 2013

Journal Articles

Germline Genetic Variation and Risk of Follicular Lymphoma Transformation in the Modern Treatment Era

James R Cerhan, MD, PhD, Grzegorz S. Nowakowski, MD, Matthew J Maurer, MS, Bridget Charbonneau, PhD, Herve Ghesquieres, MD, PhD, Anne J. Novak, Ph.D., Yan W Asmann, PhD, Ahmet Dogan, MD, PhD, Svetomir N. Markovic, MD, PhD, Carrie A. Thompson, MD, Stephen M. Ansell, M.D., Ph.D., George J. Weiner, MD, Brian K Link, MD, Thomas M Habermann, MD, Susan L Slager, PhD

Blood (2012) 120 (21): 149.

https://doi.org/10.1182/blood.V120.21.149.149

Published: 2012

Journal Articles

MYD88 Pathway Activation in Lymphoplasmacytic Lymphoma Drives Tumor Cell Growth and Cytokine Expression.

Stephen M Ansell, M.D., Ph.D., Frank J Secreto, Ph.D., Michelle Manske, Esteban Braggio, Ph.D., Lucy S. Hodge, PharmD, Ph.D., Tammy Price-Troska, Steven C. Ziesmer, Asher Alban Chanan-Khan, M.D., Morie A Gertz, M.D., Ahmet Dogan, MD, PhD, James R Cerhan, MD, PhD, Anne J Novak, Ph.D.

Blood (2012) 120 (21): 2699.

https://doi.org/10.1182/blood.V120.21.2699.2699

Published: 2012

Journal Articles

CXCR5 Polymorphisms in Non-Hodgkin Lymphoma (NHL) Risk and Prognosis.

Bridget Charbonneau, PhD, MPH, Alice H Wang, BA, Anne J. Novak, Ph.D., Stephen M. Ansell, M.D., Ph.D., Andrew L. Feldman, MD, Yan W Asmann, PhD, Julie M Cunningham, PhD, Matthew J Maurer, MS, Ahmet Dogan, MD, PhD, Thomas M Habermann, MD, Brian K Link, MD, Susan L Slager, PhD, James R Cerhan, MD, PhD

Blood (2012) 120 (21): 2702.

https://doi.org/10.1182/blood.V120.21.2702.2702

Published: 2012

Journal Articles

Biologic Activity of STAT5A and STAT5B in Waldenstrom's Macroglobulinemia.

Lucy S. Hodge, PharmD, Ph.D., Steven C. Ziesmer, Frank J Secreto, Ph.D., Zhi-Zhang Yang, MD, Anne J. Novak, Ph.D., Stephen M. Ansell, M.D., Ph.D.

Blood (2012) 120 (21): 2688.

https://doi.org/10.1182/blood.V120.21.2688.2688

Published: 2012

Journal Articles

Non-Follicular Low Grade B-Cell Lymphomas: Patterns of Presentation and Management with Comparative Prognostic Utility of IPI and FLIPI

Laura S. Jacobus, MS, Julianne Lunde, MA, Matthew J Maurer, MS, Ahmet Dogan, MD, PhD, Sergei I Syrbu, MD, Cristine Allmer, Anne J. Novak, Ph.D., James R Cerhan, MD, PhD, Grzegorz S. Nowakowski, MD, Susan L Slager, PhD, Thomas E. Witzig, MD, Carrie A. Thompson, MD, George J. Weiner, MD, Thomas M Habermann, MD, Stephen M. Ansell, M.D., Ph.D., Brian K Link, MD

Blood (2012) 120 (21): 1563.

https://doi.org/10.1182/blood.V120.21.1563.1563

Published: 2012

Journal Articles

A Lymphoma-Associated Mutation in BAFF-R Drives Constitutive PI3K Signaling and Increased Expression of Pro-Survival Genes

Frank J Secreto, Michelle K Manske, Tammy Price-Troska, Steven C. Ziesmer, Stephen M Ansell, MD, James R Cerhan, MD, PhD, Anne J. Novak, Ph.D.

Blood (2011) 118 (21): 2642.

https://doi.org/10.1182/blood.V118.21.2642.2642

Published: 2011

Journal Articles

IL-21 in the Bone Marrow Microenvironment Contributes to IgM Secretion and Proliferation of Malignant Cells in Waldenstrom's Macroglobulinemia

Lucy S. Hodge, PharmD, PhD, Steve Ziesmer, Thomas E. Witzig, MD, Anne J. Novak, Ph.D., Stephen M. Ansell, MD, PhD

Blood (2011) 118 (21): 770.

https://doi.org/10.1182/blood.V118.21.770.770

Published: 2011

Journal Articles

Pretreatment Serum Cytokines Predict Early Disease Relapse and A Poor Prognosis In Newly Diagnosed Classical Hodgkin Lymphoma (cHL) Patients

Stephen M. Ansell, MD, PhD, Matthew J Maurer, MS, Steven C. Ziesmer, Susan L Slager, PhD, Thomas M. Habermann, MD, Brian K Link, MD, Thomas E. Witzig, MD, David James Inwards, MD, Joseph P. Colgan, MD, James R Cerhan, MD, PhD, Anne J. Novak, Ph.D.

Blood (2011) 118 (21): 429.

https://doi.org/10.1182/blood.V118.21.429.429

Published: 2011

Journal Articles

Dysregulation of GPR34 in Indolent Lymphomas and Its Function As a Novel Regulator of Cell Growth and Gene Expression

Anne J. Novak, Ph.D., Takashi Akasaka, MD, PhD, Michelle K Manske, Esteban Braggio, PhD, Tammy Price-Troska, Steve Ziesmer, Secreto Frank, Ph.D., Rafael Fonseca, MD, Mamta Gupta, PhD, Mark E Law, Thomas E. Witzig, MD, Martin JS Dyer, MA, DPhil, FRCP, FRCPath, Ahmet Dogan, Ellen McPhail, MD, James R Cerhan, MD, PhD, Stephen Ansell

Blood (2011) 118 (21): 1570.

https://doi.org/10.1182/blood.V118.21.1570.1570

Published: 2011

Journal Articles

TGF-β Is Selectively Expressed on Lymphoma B Cells and Regulates the Differentiation of Intratumoral T Cells in B-Cell Non-Hodgkin Lymphoma (NHL)

Zhi-Zhang Yang, MD, Deanna Grote, Steven C. Ziesmer, Thomas E. Witzig, MD, Anne J. Novak, Ph.D., Stephen M. Ansell, MD, PhD

Blood (2011) 118 (21): 1586.

https://doi.org/10.1182/blood.V118.21.1586.1586

Published: 2011

Journal Articles

Comprehensive Analysis of the Waldenström Macroglobulinemia “Cytokine Milieu” Reveals a Novel Role of Rantes Signaling in the Regulation of Immunoglobulin Production

Sherine F. Elsawa, PhD, Anne J. Novak, Ph.D., Steven C Ziesmer, Luciana L Almada, Ph.D., Martin E Fernandez-Zapico, M.D., Thomas E Witzig, M.D., Stephen M. Ansell, M.D./Ph.D.

Blood (2008) 112 (11): 618.

https://doi.org/10.1182/blood.V112.11.618.618

Published: 2008

Journal Articles

miRNA Analysis Identifies a Unique Expression in Waldenström Macroglobulinemia B Cells and Plasma Cells

Sherine F. Elsawa, PhD, Anne J Novak, Ph.D., Deanna Grote, Thomas E Witzig, M.D., Stephen M. Ansell, M.D., Ph.D.

Blood (2008) 112 (11): 620.

https://doi.org/10.1182/blood.V112.11.620.620

Published: 2008

Journal Articles

APRIL-TACI Interactions Mediate Non-Hodgkin Lymphoma B Cell Proliferation through Akt Regulated Cyclin D1 and P21.

Mamta Gupta, PhD, Stephen M. Ansell, M.D./Ph.D., Thomas E. Witzig, M.D., Steven C. Ziesmer, James R. Cerhan, M.D., Stacey R. Dillon, Ph.D., Anne J. Novak, Ph.D.

Blood (2007) 110 (11): 3585.

https://doi.org/10.1182/blood.V110.11.3585.3585

Published: 2007

Journal Articles

Multiplex Analysis of Serum Cytokine Levels in Waldenström Macroglobulinemia Patients.

Sherine F. Elsawa, PhD, Anne J. Novak, Ph.D, Steven C. Ziesmer, Thomas E. Witzig, M.D., Vincent Rajkumar, M.D., Stephen M. Ansell, M.D./Ph.D.

Blood (2007) 110 (11): 2616.

https://doi.org/10.1182/blood.V110.11.2616.2616

Published: 2007

Journal Articles

Malignant B Cells Skew the Balance between T reg Cell and T H 17 Cell Differentiation in B-Cell Non-Hodgkin Lymphoma (NHL).

Zhi-Zhang Yang, MD, Anne J. Novak, Ph.D., Thomas E. Witzig, M.D., Stephen M. Ansell, M.D., Ph.D.

Blood (2007) 110 (11): 1347.

https://doi.org/10.1182/blood.V110.11.1347.1347

Published: 2007

Journal Articles

Role of CCL5 and Interleukin-6 in the Biology of Waldenström Macroglobulinemia.

Sherine F. Elsawa, PhD, Anne J. Novak, Ph.D., Steven C. Ziesmer, Thomas E. Witzig, M.D., Steven P. Treon, M.D./Ph.D., Steven M. Ansell, M.D./Ph.D.

Blood (2007) 110 (11): 688.

https://doi.org/10.1182/blood.V110.11.688.688

Published: 2007

Journal Articles

Preferential Inhibition of Malignant Cell Growth by CDDO in Waldenström Macroglobulinemia.

Sherine F. Elsawa, PhD, Anne J. Novak, Ph.D., Marina Konopleva, M.D., Ph.D., Michael Andreeff, M.D., Ph.D., Thomas E. Witzig, M.D., Stephen M. Ansell, M.D., Ph.D.

Blood (2006) 108 (11): 2528.

https://doi.org/10.1182/blood.V108.11.2528.2528

Published: 2006

Journal Articles

Non-Hodgkin Lymphoma B-Cells Induce Intratumoral CD4 + CD25 − T Cells To Express Foxp3 and Gain Regulatory Function.

Zhi-Zhang Yang, MD, Anne J. Novak, Ph.D, Thomas E. Witzig, M.D, Stephen M. Ansell, M.D., Ph.D

Blood (2006) 108 (11): 1724.

https://doi.org/10.1182/blood.V108.11.1724.1724

Published: 2006

Journal Articles

APRIL Promotes Survival and Proliferation of T Cells: Implications for T-Cell Lymphoma.

Zhi-Zhang Yang, M.D., Stephen M. Ansell, M.D., Ph.D., Thomas E. Witzig, M.D., Anne J. Novak, Ph.D.

Blood (2004) 104 (11): 2652.

https://doi.org/10.1182/blood.V104.11.2652.2652

Published: 2004

NARROW

Interactions Between PD-1 and PD-L1 and PD-L2 Promote Malignant B-Cell Growth in Waldenstrom Macroglobulinemia

Germline Genetic Variation and Risk of Follicular Lymphoma Transformation in the Modern Treatment Era

MYD88 Pathway Activation in Lymphoplasmacytic Lymphoma Drives Tumor Cell Growth and Cytokine Expression.

CXCR5 Polymorphisms in Non-Hodgkin Lymphoma (NHL) Risk and Prognosis.

Biologic Activity of STAT5A and STAT5B in Waldenstrom's Macroglobulinemia.

Non-Follicular Low Grade B-Cell Lymphomas: Patterns of Presentation and Management with Comparative Prognostic Utility of IPI and FLIPI

A Lymphoma-Associated Mutation in BAFF-R Drives Constitutive PI3K Signaling and Increased Expression of Pro-Survival Genes

IL-21 in the Bone Marrow Microenvironment Contributes to IgM Secretion and Proliferation of Malignant Cells in Waldenstrom's Macroglobulinemia

Pretreatment Serum Cytokines Predict Early Disease Relapse and A Poor Prognosis In Newly Diagnosed Classical Hodgkin Lymphoma (cHL) Patients

Dysregulation of GPR34 in Indolent Lymphomas and Its Function As a Novel Regulator of Cell Growth and Gene Expression

TGF-β Is Selectively Expressed on Lymphoma B Cells and Regulates the Differentiation of Intratumoral T Cells in B-Cell Non-Hodgkin Lymphoma (NHL)

Comprehensive Analysis of the Waldenström Macroglobulinemia “Cytokine Milieu” Reveals a Novel Role of Rantes Signaling in the Regulation of Immunoglobulin Production

miRNA Analysis Identifies a Unique Expression in Waldenström Macroglobulinemia B Cells and Plasma Cells

APRIL-TACI Interactions Mediate Non-Hodgkin Lymphoma B Cell Proliferation through Akt Regulated Cyclin D1 and P21.

Multiplex Analysis of Serum Cytokine Levels in Waldenström Macroglobulinemia Patients.

Malignant B Cells Skew the Balance between T reg Cell and T H 17 Cell Differentiation in B-Cell Non-Hodgkin Lymphoma (NHL).

Role of CCL5 and Interleukin-6 in the Biology of Waldenström Macroglobulinemia.

Preferential Inhibition of Malignant Cell Growth by CDDO in Waldenström Macroglobulinemia.

Non-Hodgkin Lymphoma B-Cells Induce Intratumoral CD4 + CD25 − T Cells To Express Foxp3 and Gain Regulatory Function.

APRIL Promotes Survival and Proliferation of T Cells: Implications for T-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only